JWA
VRTX icon

JFS Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

JFS Wealth Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.2K Buy
101
+3
+3% +$1.33K ﹤0.01% 551
2026
Q1 		$43.8K Sell
98
-16
-14% -$7.46K ﹤0.01% 554
2025
Q4 		$51.7K Buy
114
+25
+28% +$10.8K ﹤0.01% 509
2025
Q3 		$34.9K Hold
89
– – ﹤0.01% 578
2025
Q2 		$39.6K Sell
89
-11
-11% -$5.07K ﹤0.01% 512
2025
Q1 		$48.5K Buy
100
+1
+1% +$466 ﹤0.01% 481
2024
Q4 		$39.9K Hold
99
– – ﹤0.01% 503
2024
Q3 		$46K Buy
99
+2
+2% +$961 ﹤0.01% 485
2024
Q2 		$45.5K Sell
97
-1
-1% -$434 ﹤0.01% 433
2024
Q1 		$41K Hold
98
– – ﹤0.01% 468
2023
Q4 		$39.9K Buy
98
+10
+11% +$3.69K ﹤0.01% 444
2023
Q3 		$30.6K Hold
88
– – ﹤0.01% 447
2023
Q2 		$31K Hold
88
– – ﹤0.01% 446
2023
Q1 		$27.7K Sell
88
-10
-10% -$3K ﹤0.01% 469
2022
Q4 		$28.3K Sell
98
-11
-10% -$3.35K ﹤0.01% 461
2022
Q3 		$32K Sell
109
-116
-52% -$33.4K ﹤0.01% 468
2022
Q2 		$63K Buy
225
+90
+67% +$24.1K 0.01% 361
2022
Q1 		$35K Buy
135
+10
+8% +$2.37K ﹤0.01% 492
2021
Q4 		$27K Sell
125
-466
-79% -$90.6K ﹤0.01% 523
2021
Q3 		$107K Buy
+591
New +$115K 0.01% 294
2021
Q1 		– Sell
-44
Closed -$10K – 628
2020
Q4 		$10K Buy
+44
New +$10.1K ﹤0.01% 421
2020
Q1 		– Sell
-4
Closed -$1K – 573
2019
Q4 		$1K Hold
4
– – ﹤0.01% 498
2019
Q3 		$1K Buy
+4
New +$708 ﹤0.01% 503

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JFS Wealth Advisors's VRTX Position: Q2 2026 in Review

JFS Wealth Advisors increased its Vertex Pharmaceuticals (VRTX) stake by 3.1% in Q2 2026, buying an estimated $1.33K and bringing the position to 101 shares worth $50.2K. The position accounts for ﹤0.01% of the portfolio, ranked #551.

JFS Wealth Advisors first reported a position in VRTX in Q3 2019 and has held it in 23 quarters since. The position peaked at $107K in Q3 2021. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • JFS Wealth Advisors held 101 shares of Vertex Pharmaceuticals worth $50.2K as of Q2 2026.
  • JFS Wealth Advisors bought 3 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.33K.
  • Vertex Pharmaceuticals made up ﹤0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #551 holding.
  • JFS Wealth Advisors first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 23 quarters since.
  • JFS Wealth Advisors's Vertex Pharmaceuticals position peaked at $107K in Q3 2021.
  • 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.